Cargando…

The Relationship Between Erythropoietin Resistance and Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients

BACKGROUND: Seroconversion following Hepatitis B virus (HBV) vaccine in hemodialysis (HD) patients has been shown to be suboptimal. Nutritional and immunological factors were shown to influence the seroconversion related to HBV vaccination in HD patients. Resistance to erythropoiesis stimulating age...

Descripción completa

Detalles Bibliográficos
Autor principal:	Afsar, Baris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kowsar 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830906/ https://www.ncbi.nlm.nih.gov/pubmed/24282790 http://dx.doi.org/10.5812/numonthly.8919

Ejemplares similares

In Reply to "The Relationship Between Erythropoietin Resistance and Antibody Response to Hepatitis B Vaccine in Hemodialysis Patients"
por: Beladimusavi, Seyfollah, et al.
Publicado: (2013)

Relationship between protein-energy wasting in adults with chronic hemodialysis and the response to treatment with erythropoietin
por: González-Ortiz, Ailema, et al.
Publicado: (2019)

Variability in Response to Hepatitis B Vaccine in Hemodialysis Patients
por: El-Charabaty, Elie, et al.
Publicado: (2015)

Predicting erythropoietin resistance in hemodialysis patients with type 2 diabetes
por: Schneider, Andreas, et al.
Publicado: (2013)

Erythropoietin Resistance Development in Hemodialysis Patients: The Role of Oxidative Stress
por: Joksimovic Jovic, Jovana, et al.
Publicado: (2022)

Negative Relationship between Erythropoietin Dose and Blood Lead Level in Patients Undergoing Maintenance Hemodialysis
por: Huang, Wen-Hung, et al.
Publicado: (2016)

Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients
por: Takata, Tomoaki, et al.
Publicado: (2021)

Predictors of iron versus erythropoietin responsiveness in anemic hemodialysis patients
por: Hildebrand, Sarah, et al.
Publicado: (2022)

Pure red cell aplasia due to antibody against erythropoietin in hemodialysis patients
por: Rahbar, Maryam, et al.
Publicado: (2017)

Evaluation of Response to Hepatitis B Vaccination in Chronic Hemodialysis Patients
por: Almueilo, Samir H.
Publicado: (2017)

Do We Have to Shift Three Doses of Hepatitis B Vaccine Instead of Four Doses in Chronic Renal Failure: Think Before Action
por: Afsar, Baris
Publicado: (2013)

Oral Zinc Supplementation Reduces the Erythropoietin Responsiveness Index in Patients on Hemodialysis
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia
por: Zhu, Yifan, et al.
Publicado: (2022)

Erythropoietin-Resistant Anemia Secondary to Zinc-Induced Hypocupremia in a Hemodialysis Patient
por: Munie, Stephanie, et al.
Publicado: (2021)

Erythropoietin-producing tubercle granuloma in a hemodialysis patient
por: Satoh, Minoru, et al.
Publicado: (2013)

Obesity may be erythropoietin dose-saving in hemodialysis patients
por: El-Kannishy, Ghada M., et al.
Publicado: (2018)

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients
por: Suresh, Sukanya, et al.
Publicado: (2021)

Association between Anti-Erythropoietin Receptor Antibodies and Cardiac Function in Patients on Hemodialysis: A Multicenter Cross-Sectional Study
por: Mochida, Yasuhiro, et al.
Publicado: (2022)

Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Bae, Myoung Nam, et al.
Publicado: (2015)

Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
por: Attias, Philippe, et al.
Publicado: (2021)

The best method of hepatitis B vaccination in hemodialysis patients?
por: Momeni, Ali
Publicado: (2013)

Impaired humoral immune response to hepatitis B vaccine in patients on maintenance hemodialysis
por: Mahallawi, Waleed H., et al.
Publicado: (2023)

Successful response of intradermal hepatitis B vaccine in nonresponders of intramuscular hepatitis B vaccine in general and hemodialysis population
por: Hanif, Farina M., et al.
Publicado: (2020)

The relationship between insulin, insulin resistance, parathyroid hormone, cortisol, testosterone, and thyroid function tests in the presence of nephrolithiasis: a comprehensive analysis
por: Afsar, Baris, et al.
Publicado: (2014)

Roxadustat in the treatment of a hemodialysis patient with anti-erythropoietin antibody-mediated pure red cell aplasia
por: Xu, Bojun, et al.
Publicado: (2021)

Effects of Low-Flux and High-Flux Dialysis Membranes on Erythropoietin Responsiveness in Hemodialysis Patients
por: Abdelhamid, Walid A. R., et al.
Publicado: (2022)

Circulating growth arrest-specific protein 6 levels are associated with erythropoietin resistance in hemodialysis patients
por: Chen, Miao-Pei, et al.
Publicado: (2016)

Humoral Response to Hepatitis B and COVID-19 Vaccine among Maintenance Hemodialysis Patients
por: Nacasch, Naomi, et al.
Publicado: (2022)

Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C
por: Caliskan, Yasar, et al.
Publicado: (2012)

Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection
por: Grzegorzewska, Alicja E., et al.
Publicado: (2013)

Antibody response to COVID-19 vaccination in patients on chronic hemodialysis
por: Choi, Heejung, et al.
Publicado: (2023)

Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients
por: Coronado Daza, J. A., et al.
Publicado: (2019)

Comparing the effects of intravenous and subcutaneous Erythropoietin on blood indices in hemodialysis patients
por: Ghasemi, Faramarz, et al.
Publicado: (2019)

Long-term L-Carnitine Administration reduces Erythropoietin Resistance in Chronic Hemodialysis Patients with Thalassemia Minor
por: Di Iorio, Biagio R., et al.
Publicado: (2007)

Hemodialysis and hepatitis B vaccination: a challenge to physicians
por: Ayub¹, Munir Akar, et al.
Publicado: (2014)

Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients
por: Elghannam, Doaa M., et al.
Publicado: (2009)

Levamisole Usage as an Adjuvant to Hepatitis B Vaccine in Hemodialysis Patients, Yes or No?
por: Sanadgol, Houshang
Publicado: (2012)

The relationships between cortisol levels, insulin levels, and thyroid hormones with 24-h urinary sodium excretion in never treated essential hypertensive patients
por: Afsar, Baris, et al.
Publicado: (2014)

Resistance of dialyzed patients to erythropoietin
por: Alves, Michelle Teodoro, et al.
Publicado: (2015)

Effect of Short-term Erythropoietin Therapy on Insulin Resistance and Serum Levels of Leptin and Neuropeptide Y in Hemodialysis Patients
por: Osman, Hamed M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1tj8v1las5ht7sufedbqjqk5vq